Claris Lifesciences has informed that Board of Director of the Company has approved the sale and transfer of the equity shares of Otsuka Pharmaceutical India (formerly knowns as Claris Otsuka) held by Claris Lifesciences Limited (CLL) in its meeting held on May 8, 2017 to Otsuka Pharmaceutical Factory, Inc for a consideration of $20 million. A Press Release being issued in this regards is enclosed.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Redington | 227.50 |
| Adani Enterprises | 2228.00 |
| Amrapali Industries | 17.36 |
| Rashi Peripheral | 474.40 |
| PDS | 294.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: